After the vaccine, the Brazilian government is now surrounded by AstraZeneca, know what is the whole matter?

Brasilia. The Brazilian government is once again in controversy after Bharat Biotech canceled the purchase agreement of 20 million doses of the Kovid-19 vaccine. According to Brazilian media reports, the government is now accused of irregularities in the purchase of the AstraZeneca vaccine. Brazil’s Folha de S Paulo newspaper has claimed that the Bolsonaro government has asked for a bribe per dose for the AstraZeneca vaccine.

A Brazilian newspaper has claimed that the Bolsonaro government has demanded a bribe of US$ 1 for every dose of AstraZeneca vaccine. However, the vaccine manufacturer AstroZeneca has denied all the claims made by the newspaper. AstraZeneca has said that it does not work with any middlemen in Brazil. It has been clarified by the company that any agreements that are made are directly through Fiocruz (Osvaldo Cruz Foundation) and the federal government.

According to the newspaper report, the portfolio was sought for 400 million doses of AstraZeneca vaccine. During this time, the cost of each dose of the vaccine was 3.5 US dollars. But later the price of a vaccine dose was increased. The newspaper has claimed that a bribe of 1 US dollar has been demanded for every single dose of Corona Vaccine.

Also read:- Seven EU countries including Switzerland allowed travel to those taking Kovishield vaccine

The agreement of two crore doses of Covaxin has been canceled
Explain that the Brazilian government has postponed the agreement, which agreed to buy 20 million doses of Bharat Biotech’s anti-Kovid-19 vaccine – Covaccine. This decision has been taken at a time when Brazilian PM Jair Bolsonaro is facing allegations of corruption regarding the Corona situation and vaccination. On the other hand, Indian pharmaceutical company Bharat Biotech has said that it has not received any advance payment. The company said in a statement that we followed a ‘similar approach’ in ‘Brazil’ in terms of agreements, regulatory approvals and supplies. A media report claimed that the value of the stopped order is being estimated at around $320 million i.e. Rs 23,799,759,040 (over 23 billion).

Leave a Reply

Your email address will not be published. Required fields are marked *